Drug that ‘melts away’ tumours could replace surgery for bowel cancer, say doctors theguardian.com/society/articl…

Very happy to share our latest pre-print studying T cell dynamics in multiple myeloma disease evolution 🧵1/10. medrxiv.org/content/10.110…

🚨 Open PhD at Computational Cancer Genomics (CCG) Research Group joint with Simona Parrinello Requires bioinfo expertise and interest in participating in experiments Exciting project studying the evolution and timing of cancer invasion in GBM models and human tissues Please contact us for questions twtr.to/oMrbq

Hypermutator cancers are defined by increased mutation rates. But do mutation rates evolve with time during tumour growth?⏱️ In this work Nature Genetics we show that hypermutator cancers use an unexpected set of genetic gear switches to adapt mutation rates to immune selection.

Best of luck to our students who will be receiving their exam results ✨ If you undertook assessments this academic year, your results will be sent to your UCL email address tomorrow (4 July). Learn more about key dates and Late Summer Assessments: ucl.ac.uk/news/2024/jun/…

Join David Isenberg and me on 27th Sept in London for a fantastic masterclass on CART for autoimmunity. International guest speakers include Rich Furie, Pere Barba Jeremias Motte covering CART for lupus, myosotis, MS, M/Gravis & more! Details below-please join us! UCLH UCL Cancer Institute

Bowel cancer cells have the ability to regulate their growth using a genetic on-off switch to boost their chances of survival, a phenomenon that’s been observed for the first time by researchers including Dr Marnix Jansen from UCL Cancer Institute UCL Faculty of Medical Sciences ucl.ac.uk/news/2024/jul/…

🌟 It's STARS week! The Science Training for Aspiring Research Scientists (STARS) programme will see nearly fifty A-level students join us in our labs at Barts Cancer Institute (Queen Mary), UCL Cancer Institute and King's Faculty of Life Sciences & Medicine. The sky's the limit! 🚀 Read more: colcc.ac.uk/stars-2024/ #STARS2024

Are you a #clinician in training? Do you want to do a #PhD in #cancerresearch? 🧪🧫👩🏾‍🔬👨🏾‍🔬👩‍🔬 We opened our recruitment for the September 2025 start now! Develop a project based on your interests and background with one of our researchers. More info here: colcc.ac.uk/clinical-resea…

Big congratulations to all who received their results today! We’re excited to welcome you to UCL! ✨ ❓ Got questions about Results Day? Visit our website: ucl.ac.uk/prospective-st… #WelcomeToUCL #LoveUCL

🚨Job opportunity for bioinformatician: Come and join the Cancer Grand Challenges NexTGen team to develop T cell #immunotherapy for #childhoodcancer. For more information and to apply: ucl.ac.uk/work-at-ucl/se…

‼️Happy to share our study on #LUBAC mediating the tumorigenic potential of #LTBRsignalling. Amazing team work and super happy to be part of it!! Uniklinik Köln UCL Cancer Institute #IBMG Uni Stuttgart SFB_1403 SFB1399 #sfb1530 CDD press nature.com/articles/s4141…

Many congratulations to all our students crossing the stage today ✨ We will be cheering you on! Enjoy this special day and celebration 🎊 🎓 #UCLGrad UCL Cancer Institute UCL Division of Infection & Immunity

🚨 New research: Scientists have uncovered how the LUBAC protein complex drives inflammation that can promote liver cancer Walczak Lab buff.ly/3MuAbWC Universität zu Köln Uniklinik Köln Uni Stuttgart CDD press Nieves Peltzer CRUKCOLcentre

Such a pleasure to host you this week Adele Roberts and Kate Holderness! 💖 Adele and Kate visited our Cancer Research UK centre to meet scientists including Marnix Jansen and Kai-Keen Shiu, whose research is improving treatments for people with intestinal cancers. 🧵

Win £25k research funding! Our Datathon is open to PhDs, post docs and junior group leaders at Barts Cancer Institute (Queen Mary), UCL Cancer Institute, The Crick and King's Faculty of Life Sciences & Medicine. Use our High Performance Computing Cluster to develop a cutting-edge research proposal. Sign up by Fri 4 Oct: colcc.ac.uk/datathon-2025/

Immunotherapy for hepatocellular carcinoma - JHEP Reports jhep-reports.eu/article/S2589-… Check out this new review from our UCL/Royal Free team for a succinct update on basic and translational aspects of HCC immunotherapy #HCC UCL Cancer Institute Royal Free London IIT